BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24946862)

  • 1. Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Khasnavis S; Pahan K
    J Neuroimmune Pharmacol; 2014 Sep; 9(4):569-81. PubMed ID: 24946862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinnamon and its Metabolite Protect the Nigrostriatum in a Mouse Model of Parkinson's Disease Via Astrocytic GDNF.
    Patel D; Jana A; Roy A; Pahan K
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):503-518. PubMed ID: 31119595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinnamon in a mouse model of PD: Khasnavis S, Pahan K. Cinnamon protects dopaminergic neurons in a mouse model of Parkinson's disease. J Neuroimmune Pharmacol 2014;9:569-581.
    Fleming SM; Espay AJ
    Mov Disord; 2014 Oct; 29(12):1466. PubMed ID: 25284437
    [No Abstract]   [Full Text] [Related]  

  • 4. Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model.
    Birla H; Rai SN; Singh SS; Zahra W; Rawat A; Tiwari N; Singh RK; Pathak A; Singh SP
    Neuromolecular Med; 2019 Mar; 21(1):42-53. PubMed ID: 30644041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons.
    Khasnavis S; Pahan K
    J Neuroimmune Pharmacol; 2012 Jun; 7(2):424-35. PubMed ID: 21701815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
    Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V
    FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.
    Gottschalk CG; Jana M; Roy A; Patel DR; Pahan K
    J Neurosci; 2021 Mar; 41(10):2287-2300. PubMed ID: 33514677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice.
    Paterna JC; Leng A; Weber E; Feldon J; Büeler H
    Mol Ther; 2007 Apr; 15(4):698-704. PubMed ID: 17299411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
    Hennis MR; Marvin MA; Taylor CM; Goldberg MS
    Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Bian M; Liu J; Hong X; Yu M; Huang Y; Sheng Z; Fei J; Huang F
    PLoS One; 2012; 7(6):e39953. PubMed ID: 22792139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Castration induces Parkinson disease pathologies in young male mice via inducible nitric-oxide synthase.
    Khasnavis S; Ghosh A; Roy A; Pahan K
    J Biol Chem; 2013 Jul; 288(29):20843-20855. PubMed ID: 23744073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
    Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
    J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
    Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
    J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
    Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
    J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase.
    Hennis MR; Seamans KW; Marvin MA; Casey BH; Goldberg MS
    PLoS One; 2013; 8(12):e84894. PubMed ID: 24386432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease.
    Ren B; Zhang YX; Zhou HX; Sun FW; Zhang ZF; Wei Z; Zhang CY; Si DW
    J Neurol Sci; 2015 Jan; 348(1-2):142-52. PubMed ID: 25491263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2.
    Lev N; Barhum Y; Ben-Zur T; Aharony I; Trifonov L; Regev N; Melamed E; Gruzman A; Offen D
    PLoS One; 2015; 10(5):e0127549. PubMed ID: 26024237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of Pink1 gene in vivo sensitizes dopamine-producing neurons to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and can be rescued by autosomal recessive Parkinson disease genes, Parkin or DJ-1.
    Haque ME; Mount MP; Safarpour F; Abdel-Messih E; Callaghan S; Mazerolle C; Kitada T; Slack RS; Wallace V; Shen J; Anisman H; Park DS
    J Biol Chem; 2012 Jun; 287(27):23162-70. PubMed ID: 22511790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinnamic Acid Protects the Nigrostriatum in a Mouse Model of Parkinson's Disease via Peroxisome Proliferator-Activated Receptorα.
    Prorok T; Jana M; Patel D; Pahan K
    Neurochem Res; 2019 Apr; 44(4):751-762. PubMed ID: 30612307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.